Retatrutide: The Next-Gen ‘Triple G’ Weight Loss Drug Shows Promising Results
Retatrutide is a promising experimental weight loss drug under development by Eli Lilly. Known as the “Triple G” drug, it…
Tag: Retatrutide
Retatrutide: The Triple-Threat Obesity Drug Redefining Weight Loss Medicine
Leading the charge is retatrutide, a next-generation obesity drug developed by Eli Lilly that’s generating unprecedented excitement. Dubbed the “triple agonist,”…